STOCK TITAN
  1. Home
  2. Financials
  3. ARGX

Argenx Se Financials

ARGX
Source SEC Filings (10-K/10-Q) Data as of Mar 19, 2026 Currency USD FYE March

This page shows Argenx Se (ARGX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ARGX FY2025

argenx is running a cash-surplus, near-debt-free model where profitability and funding capacity come from operations, not lenders.

Earnings quality is decent but not one-for-one: $1.29B of net income produced $685M of operating cash flow, so reported profit is real but partly parked in working capital. Because capital intensity is minimal, with capex of $6M and free cash flow of $679M, cash generation is being shaped far more by collection timing than by heavy reinvestment needs.

Liquidity is unusually strong: cash alone at $3.49B exceeds total liabilities of $1.36B, which means day-to-day funding does not appear dependent on refinancing. Balance-sheet leverage is almost absent, with long-term debt of $36M and a current ratio of 5.2x. That gives management flexibility to fund operations or absorb setbacks without first tapping creditors.

Returns are coming from the business, not from leverage: return on assets of 14.9% sits fairly close to return on equity of 17.6%, so shareholders are not relying on borrowed money to magnify results. The very low debt load also explains why interest expense was only $3M, leaving more operating performance to flow through to net income.

Generated by Rhea from SEC filings [ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score pending refresh

We are recalculating Argenx Se's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Earnings Quality Mixed
0.53x

For every $1 of reported earnings, Argenx Se generates $0.53 in operating cash flow ($685.2M OCF vs $1.3B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$4.2B

Argenx Se generated $4.2B in revenue in fiscal year 2025.

EBITDA
N/A
Net Income
$1.3B

Argenx Se reported $1.3B in net income in fiscal year 2025.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
$679.0M

Argenx Se generated $679.0M in free cash flow in fiscal year 2025, representing cash available after capex.

Cash & Debt
$3.5B

Argenx Se held $3.5B in cash against $36.3M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
62M

Argenx Se had 62M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
30.4%

Argenx Se's net profit margin was 30.4% in fiscal year 2025, showing the share of revenue converted to profit.

Return on Equity
17.6%

Argenx Se's ROE was 17.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$6.2M

Argenx Se invested $6.2M in capex in fiscal year 2025, funding long-term assets and infrastructure.

ARGX Income Statement

ARGX Balance Sheet

ARGX Cash Flow Statement

ARGX Financial Ratios

Similar Companies

Regeneron Pharmaceuticals REGN
$69.5B
BeOne Medicines Ltd. ONC
$31.3B
Alnylam Pharmaceuticals Inc ALNY
$43.2B
Insmed Inc INSM
$25.3B
Vertex Pharmaceuticals Inc VRTX
$126.5B

Frequently Asked Questions

Argenx Se (ARGX) reported $4.2B in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Yes, Argenx Se (ARGX) reported a net income of $1.3B in fiscal year 2025, with a net profit margin of 30.4%.

As of fiscal year 2025, Argenx Se (ARGX) had $3.5B in cash and equivalents against $36.3M in long-term debt.

Argenx Se (ARGX) had a net profit margin of 30.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Argenx Se (ARGX) has a return on equity of 17.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Argenx Se (ARGX) generated $679.0M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Argenx Se (ARGX) generated $685.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Argenx Se (ARGX) had $8.7B in total assets as of fiscal year 2025, including both current and long-term assets.

Argenx Se (ARGX) invested $6.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Argenx Se (ARGX) had 62M shares outstanding as of fiscal year 2025.

Argenx Se (ARGX) had a current ratio of 5.23 as of fiscal year 2025, which is generally considered healthy.

Argenx Se (ARGX) had a debt-to-equity ratio of 0.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Argenx Se (ARGX) had a return on assets of 14.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Argenx Se (ARGX) has an earnings quality ratio of 0.53x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top